Company intelligence / Profile preview

Orasi Medical

Saint Louis Park / Edina / Minneapolis area, Minnesota, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

Orasi Medical developed the Orasi Index™, a proprietary software platform leveraging magnetoencephalography (MEG) to provide non-invasive, reproducible biomarkers for neurological diseases. The technology was used by pharmaceutical companies to accelerate CNS drug development by measuring pharmacodynamics and treatment effects in real time. The company reported positive results from clinical trials in Alzheimer's disease and multiple sclerosis before ceasing operations.

Therapeutic areas: Neurology
Modalities: DeviceSoftware as a Service
Industry: Physiological Monitoring

Partnerships

Novartis Pharmaceuticals CorporationH. Lundbeck A/S

Beyond the preview

Go deeper on Orasi Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orasi Medical.

Explore the full profile